Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul MacCartney

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|March 6, 2024
Direct induction onto high-dose long-acting injectable buprenorphine: A case seriesThileepan Naren, Jon Cook, Paul MacCartney
Drug and Alcohol Review|May 26, 2023
People who use drugs in hospital settings: 'Moving towards a person-centred harm reduction model'Thileepan Naren, Paul MacCartney, Sione Crawford, et al.
Drug and Alcohol Review|February 26, 2024
Buprenorphine microdosing regimen using transdermal buprenorphine patches to transition from methadone to buprenorphineThileepan Naren, Jon Cook, Paul MacCartney, et al.
The International Journal on Drug Policy|April 13, 2024
Time for Australia to increase take away doses in opioid agonist treatmentGrace FitzGerald, Paul MacCartney, Jon Cook, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|January 12, 2025
Patient factors associated with treatment completion in a 12-week inpatient dual diagnosis treatment programDean Membrey, Thileepan Naren, Jon Cook, et al.
Journal of Substance Use and Addiction Treatment|September 18, 2025
Feasibility of direct induction onto long-acting injectable buprenorphineThileepan Naren, Dean Membrey, Paul MacCartney, et al.
Australian Journal of General Practice|May 5, 2025
Provision of a remote telehealth opioid substitution therapy clinic in a regional Victorian communitySarah Garry, Paul MacCartney, Dean Membrey, et al.
The Medical Journal of Australia|March 5, 2025
Exploring the role of urine drug screening in opioid agonist therapyGrace FitzGerald, Sione Crawford, Adrian J Dunlop, et al.
Australian Journal of General Practice|July 2, 2026
Expanding Medicare access for treating opioid dependenceSarah Garry, Ryan D'Cunha, Hayden Green, et al.
Drug and Alcohol Review|October 3, 2025
Increasing Alcohol Pharmacotherapy Prescribing Rates in Australia: Implementing Evidence-Based Treatment for Alcohol Use DisorderThileepan Naren, Dean Membrey, Paul MacCartney, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|March 6, 2024
Direct induction onto high-dose long-acting injectable buprenorphine: A case seriesThileepan Naren, Jon Cook, Paul MacCartney
Drug and Alcohol Review|May 26, 2023
People who use drugs in hospital settings: 'Moving towards a person-centred harm reduction model'Thileepan Naren, Paul MacCartney, Sione Crawford, et al.
Drug and Alcohol Review|February 26, 2024
Buprenorphine microdosing regimen using transdermal buprenorphine patches to transition from methadone to buprenorphineThileepan Naren, Jon Cook, Paul MacCartney, et al.
The International Journal on Drug Policy|April 13, 2024
Time for Australia to increase take away doses in opioid agonist treatmentGrace FitzGerald, Paul MacCartney, Jon Cook, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|January 12, 2025
Patient factors associated with treatment completion in a 12-week inpatient dual diagnosis treatment programDean Membrey, Thileepan Naren, Jon Cook, et al.
Journal of Substance Use and Addiction Treatment|September 18, 2025
Feasibility of direct induction onto long-acting injectable buprenorphineThileepan Naren, Dean Membrey, Paul MacCartney, et al.
Australian Journal of General Practice|May 5, 2025
Provision of a remote telehealth opioid substitution therapy clinic in a regional Victorian communitySarah Garry, Paul MacCartney, Dean Membrey, et al.
The Medical Journal of Australia|March 5, 2025
Exploring the role of urine drug screening in opioid agonist therapyGrace FitzGerald, Sione Crawford, Adrian J Dunlop, et al.
Australian Journal of General Practice|July 2, 2026
Expanding Medicare access for treating opioid dependenceSarah Garry, Ryan D'Cunha, Hayden Green, et al.
Drug and Alcohol Review|October 3, 2025
Increasing Alcohol Pharmacotherapy Prescribing Rates in Australia: Implementing Evidence-Based Treatment for Alcohol Use DisorderThileepan Naren, Dean Membrey, Paul MacCartney, et al.
Pageof 2